Physician profile
William S Berger
NPI 1497715213
$9,508.94
in general payments reported to CMS, 2019-2025
7 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $123 · 2022: $7,813 · 2023: $125 · 2024: $334 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $879 · Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $878.96 |
| Food and Beverage | $694.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,860.51 | 2022-2025 | |
| Ethicon US, LLC | $193.07 | 2020-2025 | Megadyne, Echelon Endopath |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.94 | 2023 | Cycloset |
| W. L. Gore & Associates, INC. | $120.27 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Tela Bio, INC. | $109.16 | 2024 | Ovitex 2s |
| Lilly USA, LLC | $87.03 | 2024 | Omvoh |
| Integra Lifesciences Corporation | $13.96 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.